The Development of Cuba’s Biotechnology: Mechanisms and Challenges

Journal of Law, Medicine and Ethics 51 (S1):136-147 (2023)
  Copy   BIBTEX

Abstract

Cuba faces a dilemma between continuing its current portfolio of biotechnology drugs and vaccines with lower profitability or renewing its product portfolio with the associated costs and risks.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,031

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Pharmaceutical Innovation in Latin America and the Caribbean.Verónica Vargas & Jonathan Darrow - 2023 - Journal of Law, Medicine and Ethics 51 (S1):148-162.
A guide to bioethics.Emmanuel A. Kornyo - 2018 - Boca Raton: CRC Press/Taylor & Francis.
Environmental Biotechnology Research: Challenges and Opportunities in Latin America.Janeth Sanabria - 2014 - Journal of Agricultural and Environmental Ethics 27 (4):681-694.
Labeling products of biotechnology: Towards communication and consent.Debra Jackson - 2000 - Journal of Agricultural and Environmental Ethics 12 (3):319-330.
Agricultural biotechnology and the future benefits argument.Jeffrey Burkhardt - 2001 - Journal of Agricultural and Environmental Ethics 14 (2):135-145.
Biotechnology and the Fear of Frankenstein.Courtney S. Campbell - 2003 - Cambridge Quarterly of Healthcare Ethics 12 (4):342-352.

Analytics

Added to PP
2023-12-30

Downloads
12 (#1,114,191)

6 months
12 (#242,943)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references